TABLE 3.
Details for each category of underlying diseasea
| Disease type | Site or diagnosisb | Total no. of patients | No. (%) with mycosis |
|---|---|---|---|
| Solid cancers | Lung | 15,340 | 369 (2.4) |
| Stomach | 12,719 | 227 (1.8) | |
| Liver | 13,985 | 167 (1.2) | |
| Pancreas | 5,046 | 100 (2.0) | |
| Colon | 7,140 | 82 (1.1) | |
| Esophagus | 3,124 | 58 (1.9) | |
| Gall bladder | 3,478 | 67 (1.9) | |
| Breast | 2,274 | 37 (1.6) | |
| Uterus | 2,068 | 40 (1.9) | |
| Prostate | 3,278 | 29 (0.9) | |
| Ovary | 1,248 | 32 (2.6) | |
| Kidney | 2,110 | 38 (1.8) | |
| Bladder | 1,590 | 41 (2.6) | |
| Brain | 1,824 | 37 (2.0) | |
| Thyroid | 3,005 | 15 (0.5) | |
| Pharynx | 752 | 20 (2.7) | |
| Total | 78,981 | 1,359 (1.7) | |
| Blood and hematopoietic system diseases | AML | 1,753 | 620 (35.4) |
| CML | 424 | 185 (43.6) | |
| ALL | 745 | 319 (42.8) | |
| CLL | 119 | 17 (14.3) | |
| MoL | 278 | 49 (17.6) | |
| MDS | 473 | 105 (22.2) | |
| ATL | 535 | 116 (21.7) | |
| Other leukemia | 1,740 | 95 (5.5) | |
| Total for leukemia and MDS | 6,067 | 1,506 (24.8) | |
| Malignant lymphoma | 4,649 | 487 (10.5) | |
| Multiple myeloma | 1,834 | 170 (9.3) | |
| Aplastic anemia | 388 | 103 (26.5) | |
| DIC | 1,761 | 18 (1.0) | |
| Purpura | 130 | 12 (9.2) | |
| Immunological disorders | 52 | 10 (19.2) | |
| AIDS | 109 | 25 (22.9) | |
| Total for other blood and hematopoietic system diseases | 8,923 | 825 (9.2) | |
| Total | 14,990 | 2,331 (15.6) |
These data were taken from references 32, 33, 34, and 36. Among 78,981 patients with solid cancers, 1,359 patients suffered from mycoses. The mycosis rate for the solid-cancer patients was 1.7%. For blood and hematopoietic system diseases, 1,506 mycosis patients were among 6,067 leukemia and MDS patients (24.8%), and 825 patients, excluding leukemia and MDS patients, suffered from mycoses among 8,923 other patients with blood and hematopoietic system diseases (9.2%). In total, 15.6% of patients with blood and hematopoietic diseases suffered from mycoses.
AML, acute myeloid leukemia; CML, chronic myeloid leukemia; ALL, acute lymphatic leukemia; CLL, chronic lymphatic leukemia; MoL, monocystic leukemia; ATL, adult T-cell leukemia; DIC, disseminated intravascular coagulation syndrome; Purpura, idiopathic thrombocytopenic purpura or thrombotic thrombocytopenic purpura.